Impact of Serum Albumin Levels on FDG Uptake in the Liver, Spleen, and Bone Marrow During Gastrointestinal Cancer Staging: A PET-CT Study
FDG PET-CT Uptake in GIS Cancers
Abstract views: 62
/ 
PDF downloads: 34
DOI:
https://doi.org/10.5281/zenodo.13955580Keywords:
Albumin, FDG PET-CT, Gastrointestinal Cancers, Liver Metabolism, HypoalbuminemiaAbstract
Abstract:
Background: Serum albumin is an essential biomarker in cancer patients, reflecting nutritional status and systemic inflammation. This study investigates the impact of serum albumin levels on FDG uptake in the liver, spleen, and bone marrow during the staging of gastrointestinal cancers using FDG PET-CT.
Methods: This retrospective study included 610 patients with various types of cancers. FDG PET-CT scans were used to measure FDG uptake in the liver, spleen, and bone marrow. Patients were grouped into hypoalbuminemia (< 3.5 g/dL) and normal albumin levels (≥ 3.5 g/dL). The study analyzed the correlation between serum albumin and SuVMax and SuVMean of the liver, spleen, and bone marrow.
Results: Patients with normal albumin levels exhibited significantly higher liver FDG uptake, with a mean Liver SuVMax of 3.73 ± 1.78 compared to 3.32 ± 0.75 in those with hypoalbuminemia (p < 0.0001). Similarly, Liver SuVMean was higher in the normal albumin group (2.17 ± 1.20) than in the hypoalbuminemia group (1.95 ± 0.48, p = 0.0009). No significant differences in FDG uptake were observed in the spleen and bone marrow between the two groups. The study found a weak positive correlation between albumin levels and liver FDG uptake, but no significant correlation with FDG uptake in the spleen and bone marrow.
Conclusion: Serum albumin levels are significantly associated with liver FDG uptake in patients with gastrointestinal cancers, suggesting that albumin may play a role in liver metabolism. However, albumin levels do not significantly impact FDG uptake in the spleen or bone marrow. These findings highlight the potential of albumin as a marker for liver metabolism in cancer patients but suggest that other factors influence the spleen and bone marrow.
Keywords: Albumin, FDG PET-CT, Gastrointestinal Cancers, Liver Metabolism, Hypoalbuminemia
References
Tang Q, Li X, Sun CR. Predictive value of serum albumin levels on cancer survival: a prospective cohort study. Front Oncol. 2024;14:1323192. Published 2024 Mar 4. doi:10.3389/fonc.2024.1323192
Bharadwaj S, Ginoya S, Tandon P, et al. Malnutrition: laboratory markers vs nutritional assessment. Gastroenterol Rep (Oxf). 2016;4(4):272-280. doi:10.1093/gastro/gow013
Liu XY, Zhang X, Ruan GT, et al. One-Year Mortality in Patients with Cancer Cachexia: Association with Albumin and Total Protein. Cancer Manag Res. 2021;13:6775-6783. Published 2021 Aug 29. doi:10.2147/CMAR.S318728
Boonpipattanapong T, Chewatanakornkul S. Preoperative carcinoembryonic antigen and albumin in predicting survival in patients with colon and rectal carcinomas. J Clin Gastroenterol. 2006;40(7):592-595.
Suh B, Park S, Shin DW, et al. Low albumin-to-globulin ratio associated with cancer incidence and mortality in generally healthy adults. Ann Oncol. 2014;25(11):2260-2266. doi:10.1093/annonc/mdu274
Czernin J, Allen-Auerbach M, Schelbert HR. Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006. J Nucl Med. 2007;48 Suppl 1:78S-88S.
Kitajima K, Nakajo M, Kaida H, et al. Present and future roles of FDG-PET/CT imaging in the management of gastrointestinal cancer: an update. Nagoya J Med Sci. 2017;79(4):527-543. doi:10.18999/nagjms.79.4.527
Otomi Y, Otsuka H, Terazawa K, et al. A reduced liver 18F-FDG uptake may be related to hypoalbuminemia in patients with malnutrition. Ann Nucl Med. 2019;33(9):689-696. doi:10.1007/s12149-019-01377-2
Song BI. Nomogram using F-18 fluorodeoxyglucose positron emission tomography/computed tomography for preoperative prediction of lymph node metastasis in gastric cancer. World J Gastrointest Oncol. 2020;12(4):447-456. doi:10.4251/wjgo.v12.i4.447
Lee JW, Lee MS, Chung IK, Son MW, Cho YS, Lee SM. Clinical implication of FDG uptake of bone marrow on PET/CT in gastric cancer patients with surgical resection. World J Gastroenterol. 2017;23(13):2385-2395. doi:10.3748/wjg.v23.i13.2385
Kim SY, Moon CM, Yoon HJ, et al. Diffuse splenic FDG uptake is predictive of clinical outcomes in patients with rectal cancer. Sci Rep. 2019;9(1):1313. Published 2019 Feb 4. doi:10.1038/s41598-018-35912-4
Saito M, Miyazaki M, Tanino M, et al. ¹⁸F-FDG PET/CT imaging for a gastrointestinal mantle cell lymphoma with multiple lymphomatous polyposis. World J Gastroenterol. 2014;20(17):5141-5146. doi:10.3748/wjg.v20.i17.5141
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 Erdal Çetinkaya, Şadiye Altun Tuzcu
This work is licensed under a Creative Commons Attribution 4.0 International License.
The journal is licensed under a 